Jinfei Chen

5.0k total citations
130 papers, 3.5k citations indexed

About

Jinfei Chen is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Jinfei Chen has authored 130 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 67 papers in Molecular Biology, 43 papers in Oncology and 37 papers in Cancer Research. Recurrent topics in Jinfei Chen's work include Cancer-related molecular mechanisms research (23 papers), RNA modifications and cancer (21 papers) and Gastric Cancer Management and Outcomes (16 papers). Jinfei Chen is often cited by papers focused on Cancer-related molecular mechanisms research (23 papers), RNA modifications and cancer (21 papers) and Gastric Cancer Management and Outcomes (16 papers). Jinfei Chen collaborates with scholars based in China, United States and Hong Kong. Jinfei Chen's co-authors include Dongying Gu, Wei De, Erbao Zhang, Meilin Wang, Liang Han, Dandan Yin, Zhi Xu, Haiyan Chu, Xuezhi He and John M. Luk and has published in prestigious journals such as Nucleic Acids Research, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Jinfei Chen

125 papers receiving 3.5k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Jinfei Chen 2.3k 1.7k 680 448 314 130 3.5k
Wei Zhao 2.5k 1.1× 1.0k 0.6× 1.3k 1.9× 572 1.3× 280 0.9× 130 3.8k
Ning Ren 1.8k 0.8× 1.5k 0.9× 985 1.4× 443 1.0× 407 1.3× 113 3.7k
Chao Ge 2.4k 1.1× 1.7k 1.0× 1.2k 1.7× 337 0.8× 205 0.7× 87 3.9k
Catherine Muller 2.2k 1.0× 1.6k 1.0× 1.6k 2.3× 520 1.2× 244 0.8× 65 4.3k
Shicheng Guo 2.0k 0.9× 989 0.6× 476 0.7× 425 0.9× 224 0.7× 116 3.3k
Germana Castelli 1.6k 0.7× 950 0.6× 798 1.2× 400 0.9× 228 0.7× 97 3.1k
Weiyi Fang 2.9k 1.3× 1.8k 1.0× 1.0k 1.5× 319 0.7× 601 1.9× 138 4.5k
Stefanie Galbán 2.8k 1.2× 912 0.5× 1.0k 1.5× 464 1.0× 230 0.7× 74 4.5k
Bin Dong 2.0k 0.9× 738 0.4× 1.1k 1.6× 380 0.8× 283 0.9× 139 3.3k

Countries citing papers authored by Jinfei Chen

Since Specialization
Citations

This map shows the geographic impact of Jinfei Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jinfei Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jinfei Chen more than expected).

Fields of papers citing papers by Jinfei Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jinfei Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jinfei Chen. The network helps show where Jinfei Chen may publish in the future.

Co-authorship network of co-authors of Jinfei Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Jinfei Chen. A scholar is included among the top collaborators of Jinfei Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jinfei Chen. Jinfei Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yin, Dandan, Xiyi Lu, Liang Xiao, et al.. (2025). STK11 genetic alterations in metastatic EGFR mutant lung cancer. Scientific Reports. 15(1). 5729–5729.
2.
Lei, Qiqi, Jinfei Chen, Licun Wu, et al.. (2024). Burden of malignant mesothelioma in China during 1990–2019 and the projections through 2029. SHILAP Revista de lepidopterología. 4(3). 214–222. 5 indexed citations
3.
Zhang, Min, Yongran Cheng, Xiyi Jiang, et al.. (2023). Timely assessment of 5‐year relative survival of esophageal cancer patients in Taizhou, Zhejiang province. SHILAP Revista de lepidopterología. 4(3). e297–e297.
4.
5.
Ma, Zhijie, Chengfei Zhang, Qiang Zheng, et al.. (2023). RHOJ Induces Epithelial-to-Mesenchymal Transition by IL-6/STAT3 to Promote Invasion and Metastasis in Gastric Cancer. International Journal of Biological Sciences. 19(14). 4411–4426. 14 indexed citations
6.
Zhang, Min, Yongran Cheng, Bicheng Chen, et al.. (2022). Using period analysis to timely assess and predict 5‐year relative survival for colorectal cancer patients in Taizhou, eastern China. Cancer Medicine. 12(3). 3696–3704. 5 indexed citations
7.
Wang, Wentao, Xingqi Zhao, Qianwen Li, et al.. (2021). Asymmetrical arginine dimethylation of histone H4 by 8-oxog/OGG1/PRMT1 is essential for oxidative stress-induced transcription activation. Free Radical Biology and Medicine. 164. 175–186. 19 indexed citations
8.
Hensley, Patrick J., Jieming Li, Yang Zhang, et al.. (2020). Integrin-associated CD151 is a suppressor of prostate cancer progression.. PubMed Central. 12(4). 1428–1442. 10 indexed citations
9.
Chen, Yuetong, Cuiju Tang, Xiaowei Wei, et al.. (2020). Pyrotinib in the treatment of human epidermal growth factor receptor 2-positive metastatic breast cancer. Medicine. 99(25). e20809–e20809. 4 indexed citations
10.
Jie, Ying & Jinfei Chen. (2019). Combination versus mono-therapy as salvage treatment for advanced biliary tract cancer: A comprehensive meta-analysis of published data. Critical Reviews in Oncology/Hematology. 139. 134–142. 26 indexed citations
11.
Wei, Xiaowei, Yong Xu, Luksana Chaiswing, et al.. (2017). RelB Expression Determines the Differential Effects of Ascorbic Acid in Normal and Cancer Cells. Cancer Research. 77(6). 1345–1356. 37 indexed citations
12.
Yu, Shiyi, Chenxi Wu, Yan Liu, et al.. (2017). Targeting HSP90-HDAC6 Regulating Network Implicates Precision Treatment of Breast Cancer. International Journal of Biological Sciences. 13(4). 505–517. 49 indexed citations
13.
Zhang, Yangmei, Meilin Wang, Dongying Gu, et al.. (2013). Association of XRCC1 Gene Polymorphisms with the Survival and Clinicopathological Characteristics of Gastric Cancer. DNA and Cell Biology. 32(3). 111–118. 10 indexed citations
14.
Huo, Xinying, Qi Zhang, Angela M. Liu, et al.. (2012). Overexpression of Yes-associated protein confers doxorubicin resistance in hepatocellullar carcinoma. Oncology Reports. 29(2). 840–846. 77 indexed citations
15.
Wang, Qiong, Dongying Gu, Meilin Wang, et al.. (2011). The E-cadherin ( CDH1) −160C>A Polymorphism Associated with Gastric Cancer Among Asians But Not Europeans. DNA and Cell Biology. 30(6). 395–400. 16 indexed citations
16.
Liu, Jinlin, Ning Zhang, Qun Li, et al.. (2011). Tumor-Associated Macrophages Recruit CCR6+ Regulatory T Cells and Promote the Development of Colorectal Cancer via Enhancing CCL20 Production in Mice. PLoS ONE. 6(4). e19495–e19495. 208 indexed citations
17.
Gu, Dongying, Meilin Wang, Shizhi Wang, Zhengdong Zhang, & Jinfei Chen. (2011). The DNA Repair Gene APE1 T1349G Polymorphism and Risk of Gastric Cancer in a Chinese Population. PLoS ONE. 6(12). e28971–e28971. 25 indexed citations
18.
Chen, Jinfei. (2010). Progress in colitis associated colorectal cancer. Zhonghua zhongliu fangzhi zazhi. 1 indexed citations
19.
Bai, Jianling, et al.. (2009). Meta-Analysis of Chemotherapy With Irinotecan or Oxaliplatin-Involved Regimen for Untreated Metastatic Advanced Colorectal Cancer. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics. 18(9). 437–444. 7 indexed citations
20.
Schmitt, Michael, Li Li, Krzysztof Giannopoulos, et al.. (2006). Chronic myeloid leukemia cells express tumor-associated antigens eliciting specific CD8+ T-cell responses and are lacking costimulatory molecules. Experimental Hematology. 34(12). 1709–1719. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wei Zhao Breakdown of academic impact, for papers by Ning Ren Breakdown of academic impact, for papers by Chao Ge Breakdown of academic impact, for papers by Catherine Muller Breakdown of academic impact, for papers by Shicheng Guo Breakdown of academic impact, for papers by Germana Castelli Breakdown of academic impact, for papers by Weiyi Fang Breakdown of academic impact, for papers by Stefanie Galbán Breakdown of academic impact, for papers by Bin Dong
Rankless by CCL
2026